Details for New Drug Application (NDA): 084369
✉ Email this page to a colleague
NDA 084369 describes TRANMEP, which is a drug marketed by Solvay and is included in two NDAs. Additional details are available on the TRANMEP profile page.
The generic ingredient in TRANMEP is meprobamate. There are twenty-two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the meprobamate profile page.
The generic ingredient in TRANMEP is meprobamate. There are twenty-two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the meprobamate profile page.
Summary for 084369
| Tradename: | TRANMEP |
| Applicant: | Solvay |
| Ingredient: | meprobamate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 084369
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 400MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
